Hypomagnesaemia linked to depression: A systematic review and meta-analysis

Internal Medicine Journal

Volumn 45, Issue 4, 2015, Pages 436-440

  Cheungpasitporn, W ^a   Thongprayoon, C ^a   Mao, M A ^a   Srivali, N ^a   Ungprasert, P ^a   Varothai, N ^b   Sanguankeo, A ^c,d   Kittanamongkolchai, W ^a   Erickson, S B ^a  

^a MAYO CLINIC   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BASSETT MEDICAL CENTER   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Depression; Hypomagnesaemia; Magnesium; Meta analysis

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; HYPOMAGNESEMIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84964264808     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12682     Document Type: Article

References (22)

1. Derom ML, Sayon-Orea C, Martinez-Ortega JM, Martinez-Gonzalez MA. Magnesium and depression: a systematic review. Nutr Neurosci 2013; 16: 191-206.
2. Edwards CL, Green M, Wellington CC, Muhammad M, Wood M, Feliu M etal. Depression, suicidal ideation, and attempts in black patients with sickle cell disease. J Natl Med Assoc 2009; 101: 1090-1095.
3. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179-200.
4. Haensch C-A. Cerebrospinal fluid magnesium level in different neurological disorders. Neurosci Med 2010; 1: 60.
5. Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 1999; 37: 1011-1033.
6. Camardese G, De Risio L, Pizi G, Mattioli B, Buccelletti F, Serrani R etal. Plasma magnesium levels and treatment outcome in depressed patients. Nutr Neurosci 2012; 15: 78-84.
7. Jung KI, Ock SM, Chung JH, Song CH. Associations of serum ca and mg levels with mental health in adult women without psychiatric disorders. Biol Trace Elem Res 2010; 133: 153-161.
8. Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F. Depressive symptoms and hypomagnesaemia in older diabetic subjects. Arch Med Res 2007; 38: 752-756.
9. Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry 2009; 43: 45-52.
10. Young LT, Robb JC, Levitt AJ, Cooke RG, Joffe RT. Serum mg2+ and ca2+/mg2+ ratio in major depressive disorder. Neuropsychobiology 1996; 34: 26-28.
11. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ etal. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
14. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W etal. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM 2014. doi:10.1093/qjmed/hcu195
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
16. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Kittanamongkolchai W, Erickson SB. Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis. Nephrology (Carlton) 2014; 19: 791-797.
17. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872.
18. Derom ML, Martinez-Gonzalez MA, Sayon-Orea Mdel C, Bes-Rastrollo M, Beunza JJ, Sanchez-Villegas A. Magnesium intake is not related to depression risk in Spanish university graduates. J Nutr 2012; 142: 1053-1059.
19. Bresink I, Danysz W, Parsons CG, Mutschler E. Different binding affinities of NMDA receptor channel blockers in various brain regions-indication of NMDA receptor heterogeneity. Neuropharmacology 1995; 34: 533-540.
20. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev 2015; 95: 1-46.
21. Poleszak E, Szewczyk B, Kedzierska E, Wlaz P, Pilc A, Nowak G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav 2004; 78: 7-12.
22. Cardoso CC, Lobato KR, Binfare RW, Ferreira PK, Rosa AO, Santos AR etal. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 235-242.